HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central nervous system lymphoma associated with natalizumab.

Abstract
Patients with primary central nervous system lymphoma (PCNSL) after treatment with natalizumab have been considered co-incidental. We report another case of PCNSL in a patient where the explosive onset suggests a causal link.
AuthorsAngelika Na, Nick Hall, Bhadrakant Kavar, John King
JournalJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (J Clin Neurosci) Vol. 21 Issue 6 Pg. 1068-70 (Jun 2014) ISSN: 1532-2653 [Electronic] Scotland
PMID24373819 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
Topics
  • Adult
  • Antibodies, Monoclonal, Humanized (adverse effects)
  • Central Nervous System Neoplasms (chemically induced, diagnosis)
  • Fatal Outcome
  • Humans
  • Lymphoma (chemically induced, diagnosis)
  • Male
  • Natalizumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: